Summary by Moomoo AI
EC Healthcare announced on 23 January 2024 that sales for the fourth quarter of 2023 (1 October to 31 December) showed positive growth in sales in the fourth quarter of 2023 (1 October to 31 December), based on preliminary unaudited management accounts. Overall sales for the quarter are expected to be at least HK$11 billion, up more than 7% year-on-year. Among them, sales of medical services grew by more than 6%, sales of aesthetic medical, beauty and health services in Hong Kong and Macau increased by more than 5%, sales of services related to Mainland China increased by more than 3%, and sales of other services increased by more than 37%. THE BOARD OF DIRECTORS REMINDS SHAREHOLDERS AND POTENTIAL INVESTORS THAT THE ABOVE DATA IS BASED ON UNAUDITED MANAGEMENT ACCOUNTS AND HAS NOT BEEN REVIEWED OR AUDITED BY AUDITORS AND THEREFORE THE FINAL FINANCIAL PERFORMANCE MAY BE AFFECTED BY OTHER FACTORS. Investors should exercise caution when buying and selling stocks.